Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced long-term outcomes and new analyses of pivotal clinical data for EYLEA® HD (aflibercept) Injection 8 mg will be presented at the American Academy of
Exxon Mobil Corporation (NYSE: XOM) has received a letter of approval from the Ministry of Natural Resources in Guyana for its Local Content Annual Plan.